TWO SIGMA INVESTMENTS, LP – Revance Therapeutics, Inc. Transaction History
TWO SIGMA INVESTMENTS, LP portfolio value:
$30.28M
portfolio value
TWO SIGMA INVESTMENTS, LP quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +225.46% | 777.13K shares | 25.52M | $27 | 1.12M |
| Q2 2022 | share | Increase | +215.08% | 235.29K shares | 2.63M | $13.82 | 344.68K |
| Q1 2022 | share | Increase | +23.19% | 20.59K shares | 684K | $19.5 | 109.39K |
| Q4 2021 | share | Increase | 0.00% | 88.80K shares | 1.44M | $16.49 | 88.80K |
| Q4 2020 | share | Decrease | -100.00% | -32.72K shares | -823K | $28.34 | 0 |
| Q3 2020 | share | Increase | +149.61% | 19.61K shares | 503K | $25.14 | 32.72K |
| Q2 2020 | share | Decrease | -89.76% | -114.85K shares | -1.57M | $24.42 | 13.10K |
| Q1 2020 | share | Increase | +146.56% | 76.06K shares | 1.05M | $14.8 | 127.96K |
| Q4 2019 | share | Increase | 0.00% | 51.90K shares | 842K | $16.23 | 51.90K |
| Q3 2019 | share | Decrease | -100.00% | -36.24K shares | -470K | $13 | 0 |
| Q2 2019 | share | Decrease | -69.03% | -80.77K shares | -1.37M | $12.97 | 36.24K |
| Q1 2019 | share | Increase | 0.00% | 117.01K shares | 1.84M | $15.76 | 117.01K |
| Q4 2018 | share | Decrease | -100.00% | -39.03K shares | -970K | $20.13 | 0 |
| Q3 2018 | share | Decrease | -73.20% | -106.63K shares | -3.02M | $24.85 | 39.03K |
| Q2 2018 | share | Increase | +204.41% | 97.82K shares | 2.52M | $27.45 | 145.67K |
| Q1 2018 | share | Decrease | -43.13% | -36.28K shares | -1.53M | $30.8 | 47.85K |
| Q4 2017 | share | Increase | 0.00% | 84.14K shares | 3.00M | $35.75 | 84.14K |
| Q1 2016 | share | Decrease | -100.00% | -48.14K shares | -1.64M | $17.46 | 0 |